Arthrex Irap Ii System
General Drug Information and Indications
Autologous conditioned serum (IRAP) for intra-articular treatment of equine joint disease; concentrates anti-inflammatory cytokines from patient's blood for osteoarthritis.
Autologous conditioned serum (ACS) preparation system. Blood incubated with chromium sulfate-coated glass beads stimulates monocytes/macrophages to produce anti-inflammatory cytokines (especially IL-1 receptor antagonist/IL-1Ra). Concentrated serum injected intra-articularly to competitively inhibit IL-1 binding and cartilage degradation.
How to Give this Medication
Intra-articular injection: performed by veterinarian under strict aseptic conditions. Blood is collected from the patient, incubated with chromium sulfate-coated beads, centrifuged, and the resulting conditioned serum is injected intra-articularly. Use immediately after processing. Multiple joint injections possible from one blood collection.
Side Effects
Intra-articular injection: mild transient synovitis and joint effusion (normal inflammatory response). Injection site reactions. Risk of infection with any intra-articular injection (aseptic technique critical).
Precautions
For animals
Intra-articular ACS — aseptic technique essential. Restrict exercise 24–48 hrs post-injection. Do not use in joints with active septic arthritis. Blood collection from donor horse requires aseptic venipuncture.
For people handling this medication
Administered by veterinary professionals only. No specific human precautions for caregivers beyond normal hygiene.
Arthrex Irap Ii System dosage forms
| Product | Strength | Form | Size | Type |
|---|---|---|---|---|
| ARTHREX IRAP II SYSTEM | — | — | Apple | Commercial |
Sources
This information is provided for educational purposes and is not a substitute for advice from your veterinarian. Source: Plumb's Veterinary Drug Handbook (Plumb, D.C., app.plumbs.com); Merck Veterinary Manual – Joint Disorders in Horses